Champions Oncolog (CSBR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
| 04-2010 | 04-2009 | 04-2008 | 04-2007 | 04-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,572 | 1,728 | 3,709 | 4 | 1 |
| Marketable Securities | N/A | 1,017 | N/A | N/A | N/A |
| Receivables | 89 | N/A | N/A | N/A | N/A |
| TOTAL | $3,158 | $3,870 | $3,762 | $4 | $1 |
| Non-Current Assets | |||||
| PPE Net | 105 | 81 | N/A | N/A | N/A |
| Intangibles | 669 | 669 | 889 | 180 | 0 |
| TOTAL | $774 | $750 | $889 | $180 | $N/A |
| Total Assets | $3,932 | $4,620 | $4,651 | $184 | $1 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 944 | 1,414 | 113 | 93 | 33 |
| Accrued Expenses | 236 | 67 | 35 | N/A | N/A |
| TOTAL | $2,090 | $2,704 | $1,014 | $445 | $671 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 910 | 1,223 | 505 | N/A | N/A |
| Other Non-Current Liabilities | 265 | 0 | 0 | 0 | 0 |
| TOTAL | $265 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,355 | $2,704 | $1,014 | $445 | $671 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,974 | 2,717 | 2,772 | 2,634 | 1,401 |
| Common Shares | 37 | 34 | 33 | 28 | 17 |
| Retained earnings | -12,680 | -9,757 | -7,515 | -7,104 | -6,934 |
| Other shareholders' equity | -973 | -1 | 0 | -33 | 0 |
| TOTAL | $1,577 | $1,916 | $3,637 | $-261 | $-671 |
| Total Liabilities And Equity | $3,932 | $4,620 | $4,651 | $184 | $1 |